Since the dawn of civilization, humans have been puzzled about the effect of time on our physiology and decay. Only in the last decades notable advances have been made as we begin to unravel the causes and mechanisms of aging. On one hand, it is clear that epigenetic alterations accumulate with age, leading to disrupted cell function and tissue pathology. Exciting advances are now exploring whether epigenetic reprogramming can be sufficient to revert the phenotypic traits of aged organs. On the other hand, provoking new studies are increasingly supporting the mutational hypothesis of aging. It is evident that some stem cell clones acquire somatic mutations that endow them with a self-renewal advantage, leading to their expansion and tissue-takeover in old age. Various researchers are beginning to explore how clonal mosaicism can contribute to organismal aging across scales. At the crossroads of these hypotheses lies the blood and immune system, which pervades most organs and contributes to various critical mechanisms of aging and tumor control.
Presentation
Conference description
This conference will provide an interdisciplinary forum for researchers interested in aging, somatic mosaicism, epigenetics, plasticity, stem cells and immunity. We will give specific focus to methodological and quantitative advances from the fields of genomics and single-cell biology, which have led to a revolution in the way we are understanding aging and tumor evolution. A true synthesis of all these fields will be required to identify the best avenues to delay the onset of age-related diseases in the elderly.
Conference organizers
Dr. Alejo Rodriguez-Fraticelli
IRB Barcelona
Barcelona, Spain
Dr. Salvador Aznar Benitah
IRB Barcelona/ ICREA
Barcelona, Spain
Dr. John E. Dick
University Health Network
Toronto, ON, Canada
There is no registration fee for this conference, but the number of participants is limited, with a number of seats saved for IRB Barcelona alumni. Previous registration is required.
Participants are invited to submit abstracts, a number of which will be selected for short talk and poster presentations. Abstracts should include a title, authors, affiliations, summary (max 250 words) and references
REGISTRATION DEADLINE: 10 OCTOBER, 2022
Programme
Monday, 14 November
8.30 Registration
9.00 Welcome by Dr. Raúl Méndez (IRB Barcelona, Vice Director) and organizers (Dr. Alejo Rodriguez-Fraticelli, Dr. John E. Dick, Dr. Salvador Aznar-Benitah)
Session 1: Deregulated stem cell mechanisms in aging and cancer
Chair: Dr. Salvador Aznar-Benitah
9.15 What Makes a Stem Cell a Stem Cell and How Does it Go Bad in AML
Dr. John E. Dick, University Health Network (Toronto, ON, Canada)
9.50 Clonally resolved single-cell multi-omics identifies routes of cellular differentiation in acute myeloid leukemia
Dr. Lars Velten, CRG (Barcelona, Spain)
10.25 Short talk 1: Understanding the role of PHF19 in acute Myeloid leukemias (AMLs): from patients data analysis to cell in-vitro characterization
Gianni Paolo Gamarra Figueroa, CRG (Barcelona, Spain)
10.40-11.15 Coffee break and poster session
11.15 Somatic evolution in normal and neoplastic hematopoiesis through the lens of single-cell multi-omics
Dr. Dan A. Landau, New York Genome Center (New York, NY, USA)
11.50 Clonal determinants of stem cell heterogeneity
Dr. Alejo Rodriguez-Fraticelli, IRB Barcelona (Barcelona, Spain)
12:25 Principles of regeneration captured by imaging the skin of live mice
Dr. Valentina Greco, Yale University School of Medicine (New Haven, CT, USA)
13.00 Short talk 2: Stromal niche instructs early tumour formation
Dr. Maria P. Alcolea, Wellcome – MRC Cambridge Stem Cell Institute (Cambridge, UK)
13.15-15.00 Lunch and poster session
Session 2: Dynamics of aging
Chair: Dr. Alejo Rodriguez-Fraticelli
15.00 A map of circulating HSCs in age and disease
Dr. Liran Shlush, Weizmann Institute of Science (Rehovot, Israel)
15.35 Systemic regulation of physiology by circadian clocks in youth and during aging
Dr. Salvador Aznar-Benitah, IRB Barcelona/ ICREA (Barcelona, Spain)
16.10 Short talk 3: Protective role of cellular heterogeneity preserving the plasticity and complexity of transcriptional networks during ageing
Dr. Celia P. Martinez-Jimenez, Helmholtz Zentrum Munchen (München, Germany)
16.25-16.55 Coffee break and poster session
16.55 New approaches to enhance regeneration of aged muscles: a focus on senescent cells
Dr. Pura Muñoz-Cánoves, UPF (Barcelona, Spain)
17.30 Intestinal Stem Cell Aging: local and systemic effects
Dr. Heinrich Jasper, Genentech Inc. (South San Francisco, CA, USA)
18.00 Short talk 4: Genome segmentation by UV light DNA damage repair dynamics
Hanna Kranas, IRB Barcelona (Barcelona, Spain)
18.15 End of session
Tuesday, 15 November
Session 3: Clonal evolution in aging and cancer
Chair: Dr. Alejo Rodriguez-Fraticelli
9.00 Somatic mutations in tumors and normal tissues
Dr. Núria López-Bigas, IRB Barcelona/ ICREA (Barcelona, Spain)
9.35 Somatic mutation in normal tissues
Dr. Iñigo Martincorena, Wellcome Sanger Institute (Cambridge, UK)
10.10 Short talk 5: Genome-wide analyses of 200,453 individuals yields new insights into the causes and consequences of clonal hematopoiesis
Dr. Pedro M. Quiros, Instituto de Investigación Sanitaria del Principado de Asturias (Oviedo, Asturias)
10.25 Short talk 6: Somatic LMNA mutation and expression of progerin in early vascular aging of chronic kidney disease
Dr. Gwladys Revêchon, Karolinska Institutet (Huddinge, Sweden)
10.40-11.10 Coffee break and poster session
11.10 Injury-induced cellular reprogramming as a driver of preneoplastic transformation and tumour initiation in epithelial tissues
Dr. Benjamin D. Simons, Wellcome Trust-Cancer Research UK Gurdon Institute (Cambridge, UK)
11.45 Haematopoiesis across the human lifespan at single cell resolution
Dr. Elisa Laurenti, Wellcome-MRC Cambridge Stem Cell Institute (Cambridge, UK)
12.20 Genetic determinants of clonal expansion rate in pre-malignant HSCs
Dr. Siddartha Jaiswal, Stanford Medicine (Stanford, CA, USA)
12.55 Short talk 7: Identification of Clonal Hematopoiesis Driver Mutations through In Silico Saturation Mutagenesis
Dr. Santiago Demajo, IRB Barcelona (Barcelona, Spain)
13.10-15.00 Lunch and poster session
Session 4: Immune processes
Chair: Dr. Salvador Aznar-Benitah
15.00 Circadian biology in the bone marrow
Dr. Andrés Hidalgo, CNIC (Madrid, Spain)
15.35 Rejuvenated blood stem cells extend lifespan of aged immunocompromised mice
Dr. Maria Carolina Florian, IDIBELL (Barcelona, Spain)
16.10 Short talk 8: Clonal haematopoiesis shapes the immune system: the case of the preleukemic neutrophil
Dr. Hector Huerga, The Francis Crick Institute (London, UK)
16.25-17.00 Coffee break and poster session
17.00 Short talk 9: Age-associated T cells drive myelopoiesis skewing in old mice
Dr. Enrique Gabandé-Rodríguez, CBM- CSIC (Madrid, Spain)
17.10 Short talk 10: Local IL-17 orchestrates skin aging
Dr. Guiomar Solanas, IRB Barcelona (Barcelona, Spain)
17.30 End of session
20.30 Speakers dinner (Restaurant Can Pineda) (Sant Joan de Malta, 55)
Wednesday, 16 November
Session 5: Cell plasticity, aging and cancer
Chair: Dr. Salvador Aznar-Benitah
9.00 Formaldehyde induced endogenous DNA damage disrupts blood regeneration, nutritional homeostasis and promotes ageing
Dr. Ketan J. Patel, MRC Weatherall Institute of Molecular Medicine (Oxford, UK)
9.35 Understanding and controlling cellular plasticity
Dr. Manuel Serrano, IRB Barcelona/ ICREA (Barcelona, Spain)
10.10 Short talk 11: Organelle age landscape in skin
Dr. Agustin Sola Carvajal, Karolinska Institute (Stockholm, Sweden)
10.25-11.00 Coffee break and poster session
11.00 Neoplastic co-option of epigenetic plasticity and epithelial-immune interactions
Dr. Direna Alonso-Curbelo, IRB Barcelona (Barcelona, Spain)
11.35 Regulation of stem cell fate and dynamics by niche derived factors and forces
Dr. Sara Wickström, Faculty of Medicine and Helsinki Institute of Life Science (Helsinki, Finland)
12.10 Nutrient dependencies of metastasis formation
13.00 Concluding remarks and end of conference
Venue
The BARCELONA BIOMED CONFERENCE Quantitative dynamics of aging and premalignancy will be placed at the Casa Convalescència in the heart of Barcelona. Talks will take place in the Aula Magna.
Casa Convalescència
C/ Sant Antoni Maria Claret, 171
08041 Barcelona
Tel +34 934 335 000
www.uab-casaconvalescencia.org
How to reach the Casa Convalescència:
Underground
Yellow line (L4) - GUINARDÓ – HOSPITAL DE SANT PAU station
Blue line (L5) - SANT PAU – DOS DE MAIG station
By bus
Lines: 15, 19, 20, 45, 47, 50, 51, 92 and 192.
For the GPS
Introduce the following coordinates:
Latitude: 41.413702 (41° 24' 49.33'' N)
Longitude: 2.177482 (2° 10' 38.94'' E)
From the airport
* Train + Underground. At the RENFE station, take the train to Sants-Estació. Once there take the Underground's blue line (L5) till SANT PAU – DOS DE MAIG station.
* Bus + Underground. Outside the airport terminal, take the AEROBUS to Plaça Catalunya. Walk one corner till Plaça Urquinaona and take the Underground's yellow line (L4) to GUINARDÓ – HOSPITAL DE SANT PAU station.
Barcelona Metropolitan Transport webiste (with metro and bus maps)
Accomodation
Speakers will be lodged at the Hotel Catalonia Atenas
Av. Meridiana, 151
08026, Barcelona
Telephone: +34 93 232 20 11
e-mail: catalonia@cataloniahotels.com
www.hoteles-catalonia.com
Other hotels
A list of additional hotels within walking distance of the Casa Convalescència can be found at: https://www.barcelona-tourist-guide.com/en/hotels/hotelmaps/eixample-right-barcelona-hotel.html
(The Casa Convalescència is located near the violet point 27/3 star). Rates will vary depending on choice of hotel and season. Please check with the hotel of your choice directly for the best offer.
Residences
Another possibility is the Lesseps Residence Hall, and is available for short-term stays.
Lesseps Residence Hall
Plaza Lesseps, 12 08023 Barcelona
View on map
Telephone: +34 933 941 600
e-mail: lesseps@resa.es
www.resa.es/en/city/barcelona
Participants registered for events in the Barcelona BioMed series should contact the hotels and residences directly to arrange bookings and payment.
Speakers
Dr. Direna Alonso-Curbelo
IRB Barcelona
Barcelona, Spain
Dr. Sarah -Maria Fendt
VIB - KU Leuven Center for Cancer Biology
Leuven, Belgium
Dr. Maria Carolina Florian
IDIBELL
Barcelona, Spain
Dr. Valentina Greco
Yale University School of Medicine
New Haven, CT, USA
Dr. Andrés Hidalgo
CNIC
Madrid, Spain
Dr. Siddartha Jaiswal
Stanford Medicine
Stanford,CA, USA
Dr. Heinrich Jasper
Genentech Inc.
South San Francisco, CA, USA
Dr. Dan A. Landau
New York Genome Center
New York, NY, USA
Dr. Elisa Laurenti
Wellcome-MRC Cambridge Stem Cell Institute
Cambridge, UK
Dr. Núria López-Bigas
IRB Barcelona/ ICREA
Barcelona, Spain
Dr. Iñigo Martincorena
Wellcome Sanger Institute
Cambridge, UK
Dr. Pura Muñoz-Cánoves
UPF
Barcelona, Spain
Dr. Ketan J. Patel
MRC Weatherall Institute of Molecular Medicine
Oxford, UK
Dr. Manuel Serrano
IRB Barcelona/ ICREA
Barcelona, Spain
Dr. Liran Shlush
Weizmann Institute of Science
Rehovot, Israel
Dr. Benjamin D. Simons
Wellcome Trust-Cancer Research UK Gurdon Institute
Cambridge, UK
Dr. Lars Velten
CRG
Barcelona, Spain
Dr. Sara Wickström
Faculty of Medicine and Helsinki Institute of Life Science
Helsinki, Finland